BELITE BIO, INC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 43.2 USD | +5.11% |
|
+8.68% | -5.57% |
| 26/04 | Belite Bio Unveils Plan to Offer 651,380 American Depository Shares | MT |
| 22/03 | Belite Bio Completes Regulatory Submission for Tinlarebant's Clinical Trial in Japan | MT |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Neutral | Bullish |
| Resistance | 43.95 | 48.01 | 47.61 |
| Spread/Res. | -1.71% | -10.02% | -9.26% |
| Spread/Supp. | +33.62% | +33.62% | +83.99% |
| Support | 32.33 | 32.33 | 23.48 |
Technical Rankings Surperformance
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- BLTE Stock
- Charts Belite Bio, Inc